14-95535130-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016417.3(GLRX5):c.41G>T(p.Arg14Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000885 in 1,242,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_016417.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLRX5 | NM_016417.3 | c.41G>T | p.Arg14Leu | missense_variant | Exon 1 of 2 | ENST00000331334.5 | NP_057501.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLRX5 | ENST00000331334.5 | c.41G>T | p.Arg14Leu | missense_variant | Exon 1 of 2 | 1 | NM_016417.3 | ENSP00000328570.4 | ||
GLRX5 | ENST00000553672.1 | n.301+1327G>T | intron_variant | Intron 1 of 1 | 2 | |||||
GLRX5 | ENST00000557731.1 | c.-145G>T | upstream_gene_variant | 5 | ENSP00000451800.1 | |||||
SNHG10 | ENST00000660378.3 | n.-241C>A | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151164Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000825 AC: 9AN: 1091168Hom.: 0 Cov.: 31 AF XY: 0.00000568 AC XY: 3AN XY: 528260
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151272Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 73940
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.41G>T (p.R14L) alteration is located in exon 1 (coding exon 1) of the GLRX5 gene. This alteration results from a G to T substitution at nucleotide position 41, causing the arginine (R) at amino acid position 14 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with GLRX5-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 14 of the GLRX5 protein (p.Arg14Leu). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at